Vill K, Muller-Felber W, Landfarth T, Koppl C, Herzig N, Knerr C, Holla H, Steidle G, Harms E, Hohenfellner K, Interdisciplinary Cystinosis Group (2022) Neuromuscular conditions and the impact of cystine-depleting therapy in infantile nephropathic cystinosis: a cross-sectional analysis of 55 patients
Warning : It's crucial to consult with a healthcare provider before starting any new supplement regimen, especially for individuals with pre-existing health conditions
NRF2: new mechanistic insights and therapeutic perspectives
Concentration = 10,000mcg / 200 units = 50mcg per unit
Tell your provider so doses can be adjusted or spaced out safely